Suscribirse

Salsalate, morphine, and postoperative ileus - 11/09/11

Doi : 10.1016/S0002-9610(99)80079-8 
Guozhang Cheng, MD a, Christopher Cassissi, MS a, P. Greg Drexler, PharmD c, Stephen B. Vogel, MD a, Charles A. Sninsky, MD b, Michael P. Hocking, MD , a
a From the Departments of Surgery (GC, CC, SBV, MPH), University of Florida College of Medicine, and the Veterans Affairs Medical Center, Gainesville, Florida, USA 
b From the Departments of Medicine (CAS), University of Florida College of Medicine, and the Veterans Affairs Medical Center, Gainesville, Florida, USA 
c From the Departments of Pharmacy(GD), University of Florida College of Medicine, and the Veterans Affairs Medical Center, Gainesville, Florida, USA 

*Requests for reprints should be addressed to Michael P. Hocking, MD, Surgical Service (112G), Gainesville VAMC, 1601 SW Archer Road, Gainesville, Florida 32608-1197.

Presented at the 36th Annual Meeting of the Society for Surgery of the Alimentary Tract, San Diego, California, May 14–17, 1995.

Abstract

Background

Previously, we demonstrated that ketorolac, a nonsteroidal antilnflammatory drug (NSAID), prevented postoperative small bowel ileus in a rodent model. The aim of this study was to evaluate the effect of salsalate, an NSAID without antlplatelet effect, on postoperative ileus alone or in combination with morphine.

Methods

Forty-eight rats underwent placement of duodenal catheters and were then randomly assigned to one of eight groups (n = 6). Four groups had standardized laparotomy following drug administration, whereas 4 groups underwent the same treatment without laparotomy: control and morphine animals received 0.1 mL alcohol via the catheter, whereas salsalate and salsalate-plus-morphine animals received salsalate (15 mg/kg) dissolved in 0.1 mL alcohol. The animals also received 0.5 mg/kg morphine (morphine and salsalate plus morphine) or the same volume of saline (control and salsalate) subcutaneously. Transit was measured following the injection of a nonabsorbed marker via the duodenal catheter and is defined as the geometric center (GC) of distribution. An additional 20 rats had serosal electrodes placed on the jejunum, and were assigned to one of four treatment groups (control, salsalate, morphine, and salsalate plus morphine; n = 5 each group). Myoelectric activity was recorded until the reappearance of the migrating myoelectric complex (MMC) following laparotomy.

Results

Laparotomy and morphine independently reduced small bowel transit (P = 0.0006 and 0.006, respectively, by three-way analysis of variance [ANOVA]; GC 4.3 ± 0.2 control versus 2.2 ± 0.3 laparotomy versus 3.6 ± 0.4 morphine), but morphine did not further worsen postoperative transit (GC 2.4 ± 0.4; P = 0.42). Although salsalate did not alter baseline transit, pretreatment improved postoperative transit (P = 0.0002; GC 3.6 ± 0.4). This effect was lost with the addition of morphine (GC 2.7 ± 0.2; P = 0.21). The MMCs returned earlier after laparotomy in salsalate-pretreated rats (63 ± 18 minutes salsalate versus 160 ±12 minutes laparotomy; P <0.01, one-way ANOVA). However, this effect was also lost in animals receiving morphine (106 ± 16 min; P >0.05).

Conclusion

Salsalate improves postoperative small bowel motility in a rodent model; however, this effect is masked by morphine.

El texto completo de este artículo está disponible en PDF.

* Supported by the Medical Research Service of the Department of Veterans Affairs.


© 1996  Publicado por Elsevier Masson SAS.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 171 - N° 1

P. 85-89 - janvier 1996 Regresar al número
Artículo precedente Artículo precedente
  • Greater risk of incisional hernia with morbidly obese than steroid-dependent patients and low recurrence with prefascial polypropylene mesh
  • Harvey J. Sugerman, John M. Kellum, H. David Reines, Eric J. DeMaria, Heber H. Newsome, James W. Lowry
| Artículo siguiente Artículo siguiente
  • Delayed gastroduodenal emptying is an important mechanism for control of intestinal transit in short-gut syndrome
  • Christopher P. Johnson, Sushil K. Sama, Yong-ran Zhu, Ellen Buchmann, Laurie Bonham, Gordon L. Telford, Allan M. Roza, Mark B. Adams

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.